PubMed COVID-19 Clinical Care
1931 - 1940 of 2196 results found
Reliability of the five times sit to stand test performed remotely by multiple sclerosis patients
Description
CONCLUSION: Based on these values, FTSST performed remotely and synchronously by relapsing-remitting Multiple Sclerosis patients is reliable and can be used both by different raters, for assessment, or by the same rater, in pre- and post-test
Remdesivir
Description
Remdesivir, marketed under the brand name Veklury, is an antiviral drug with a broad spectrum of activity. There were various countries where the use of Remdesivir for the treatment of COVID-19 was authorized during the pandemic. Remdesivir was first
Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis
Description
CONCLUSIONS: Our findings suggest that new-onset HT represents an important post-acute COVID-19 sequelae.
Remote patient monitoring following full endoscopic spine surgery: feasibility and patient satisfaction
Description
CONCLUSIONS: Postoperative remote patient monitoring and communication after full endoscopic surgery is feasible using the SPINEhealthie app. Importantly, patients were willing to share their medical information using a mobile device, and they were
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies
Description
Across North America, overlapping overdose and COVID-19 emergencies have had a substantial impact on young people who use drugs (YPWUD). New risk mitigation guidance (RMG) prescribing practices were introduced in British Columbia, Canada, in 2020 to
Risk of Type 1 Diabetes in Children Is Not Increased After SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
Description
CONCLUSIONS: Our data do not support that SARS-CoV-2 infection is associated with type 1 diabetes or that type 1 diabetes should be a special focus after a SARS-CoV-2 infection in children.
Reports analysis of psychotropic drugs related adverse reactions in Australia and Poland during the COVID 19 pandemic
Description
BACKGROUND: The COVID-19 pandemic has caused significant changes to the global health care system AIMS: It is unknown whether the COVID-19 pandemic influenced the occurrence of adverse drug reactions (ADR) of antidepressive agents, benzodiazepines
Restoring the sense of smell to COVID-19 patients
Description
No abstract
Rebound Symptoms Common With COVID-19 Even After Placebo Treatment
Description
No abstract
